{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:44:28Z","timestamp":1786729468076,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100021316","name":"AstraZeneca United States","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s40121-026-01402-8","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:10:14Z","timestamp":1783599014000},"page":"2477-2489","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of the Hospital Burden Associated with Respiratory Syncytial Virus and Human Metapneumovirus Across All Age Groups in Scotland: A Retrospective Analysis"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7680-1168","authenticated-orcid":false,"given":"Durga","family":"Kulkarni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Osei-Yeboah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Templeton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9432-9100","authenticated-orcid":false,"given":"Harish","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"issue":"12","key":"1402_CR1","doi-asserted-by":"publisher","first-page":"e705","DOI":"10.1016\/S1473-3099(25)00240-3","volume":"25","author":"J-W Liu","year":"2025","unstructured":"Liu J-W, Lai C-C, Hsueh P-R. Resurgence of human metapneumovirus in the post-COVID-19 era: pathogenesis, epidemiological shifts, clinical impact, and future challenges. Lancet Infect Dis. 2025;25(12):e705\u201321.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"1402_CR2","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12985-025-02782-y","volume":"22","author":"K Mohammadi","year":"2025","unstructured":"Mohammadi K, Faramarzi S, Yaribash S, Valizadeh Z, Rajabi E, Ghavam M, et\u00a0al. Human metapneumovirus (hMPV) in 2025: emerging trends and insights from community and hospital-based respiratory panel analyses\u2014A comprehensive review. Virol J. 2025;22(1):150.","journal-title":"Virol J"},{"issue":"4","key":"1402_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s40266-015-0258-9","volume":"32","author":"AR Branche","year":"2015","unstructured":"Branche AR, Falsey AR. Respiratory syncytial virus infection in older adults: an under-recognized problem. Drugs Aging. 2015;32(4):261\u20139.","journal-title":"Drugs Aging"},{"key":"1402_CR4","unstructured":"Centers for Disease Control and Prevention. About Human Metapneumovirus: U.S. Centers for Disease Control and Prevention; 2026 [Available from: https:\/\/www.cdc.gov\/human-metapneumovirus\/about\/index.html."},{"key":"1402_CR5","unstructured":"Public Health Scotland. Scotland\u2019s\u202fnew life-saving Respiratory Syncytial Virus (RSV) vaccination programme begins 2024 [Available from: https:\/\/publichealthscotland.scot\/news\/2024\/august\/scotland-s-new-life-saving-respiratory-syncytial-virus-rsv-vaccination-programme-begins\/."},{"issue":"3","key":"1402_CR6","doi-asserted-by":"publisher","first-page":"e2024070218","DOI":"10.1542\/peds.2024-070218","volume":"156","author":"LA Goldstein","year":"2025","unstructured":"Goldstein LA, Michaels MG, Salthouse A, Toepfer AP, Musa S, Hickey RW, et\u00a0al. Human metapneumovirus and respiratory syncytial virus in children: a comparative analysis. Pediatrics. 2025;156(3):e2024070218.","journal-title":"Pediatrics."},{"issue":"2","key":"1402_CR7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3201\/eid2802.211727","volume":"28","author":"J Piret","year":"2022","unstructured":"Piret J, Boivin G. Viral interference between respiratory viruses. Emerg Infect Dis. 2022;28(2):273.","journal-title":"Emerg Infect Dis"},{"key":"1402_CR8","doi-asserted-by":"publisher","first-page":"251513552413106","DOI":"10.1177\/25151355241310601","volume":"13","author":"K Kelleher","year":"2025","unstructured":"Kelleher K, Subramaniam N, Drysdale SB. The recent landscape of RSV vaccine research. Ther Adv Vaccin Immunother. 2025;13:25151355241310600.","journal-title":"Ther Adv Vaccin Immunother"},{"key":"1402_CR9","unstructured":"Public Health Scotland. General Acute Inpatient and Day Case - Scottish Morbidity Record (SMR01) 2024 [Available from: https:\/\/publichealthscotland.scot\/resources-and-tools\/health-intelligence-and-data-management\/national-data-catalogue\/national-datasets\/search-the-datasets\/general-acute-inpatient-and-day-case-scottish-morbidity-record-smr01\/."},{"issue":"Supplement_1","key":"1402_CR10","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1093\/infdis\/jiac150","volume":"226","author":"CK Johannesen","year":"2022","unstructured":"Johannesen CK, van Wijhe M, Tong S, Fern\u00e1ndez LV, Heikkinen T, van Boven M, et\u00a0al. Age-specific estimates of respiratory syncytial virus-associated hospitalizations in 6 European countries: a time series analysis. J Infect Dis. 2022;226(Supplement_1):S29\u201337.","journal-title":"J Infect Dis"},{"key":"1402_CR11","unstructured":"Public Health Scotland. Electronic Communication of Surveillance Scotland (ECOSS) 2024 [Available from: https:\/\/publichealthscotland.scot\/resources-and-tools\/health-intelligence-and-data-management\/national-data-catalogue\/national-datasets\/search-the-datasets\/electronic-communication-of-surveillance-scotland-ecoss\/."},{"key":"1402_CR12","volume-title":"Human metapneumovirus-associated hospital burden in older adults in Scotland: a retrospective analysis. Open forum infectious diseases","year":"2026","unstructured":"Kulkarni D, Osei-Yeboah R, Templeton K, Nair H, editors. Human metapneumovirus-associated hospital burden in older adults in Scotland: a retrospective analysis. Open forum infectious diseases. Oxford: Oxford University Press; 2026."},{"key":"1402_CR13","unstructured":"Public Health Scotland. Overview of SICSAG 2025 [Available from: https:\/\/publichealthscotland.scot\/resources-and-tools\/health-strategy-and-outcomes\/scottish-national-audit-programme-snap\/scottish-intensive-care-society-audit-group-sicsag\/overview-of-sicsag\/about-sicsag\/."},{"key":"1402_CR14","unstructured":"Public Health Scotland. National Records of Scotland (NRS): Deaths Data 2024 [Available from: https:\/\/publichealthscotland.scot\/resources-and-tools\/health-intelligence-and-data-management\/national-data-catalogue\/national-datasets\/search-the-datasets\/national-records-of-scotland-nrs-deaths-data\/."},{"issue":"3","key":"1402_CR15","first-page":"1940","volume":"7","author":"D Clark","year":"2022","unstructured":"Clark D, Reid J, Bailey D, Iqbal S, Clydesdale H, Humphreys K, et\u00a0al. Revisiting the quality of the Scottish record linkage system. Int J Popul Data Sci. 2022;7(3):1940.","journal-title":"Int J Popul Data Sci"},{"key":"1402_CR16","unstructured":"National Records of Scotland. Mid-2023 population estimates 2024 [Available from: https:\/\/www.nrscotland.gov.uk\/publications\/mid-2023-population-estimates\/."},{"key":"1402_CR17","unstructured":"National Records of Scotland. Rebased population estimates, Scotland, mid-2011 to mid-2021 2025 [Available from: https:\/\/www.nrscotland.gov.uk\/publications\/rebased-population-estimates-scotland-mid-2011-to-mid-2021\/."},{"issue":"7","key":"1402_CR18","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1177\/01410768231223584","volume":"117","author":"T Shi","year":"2024","unstructured":"Shi T, Millington T, Robertson C, Jeffrey K, Katikireddi SV, McCowan C, et\u00a0al. Risk of winter hospitalisation and death from acute respiratory infections in Scotland: national retrospective cohort study. J R Soc Med. 2024;117(7):232\u201346.","journal-title":"J R Soc Med"},{"issue":"6","key":"1402_CR19","doi-asserted-by":"publisher","first-page":"e1005","DOI":"10.1016\/S2214-109X(24)00090-1","volume":"12","author":"L Guo","year":"2024","unstructured":"Guo L, Deng S, Sun S, Wang X, Li Y. Respiratory syncytial virus seasonality, transmission zones, and implications for seasonal prevention strategy in China: a systematic analysis. Lancet Glob Health. 2024;12(6):e1005\u201316.","journal-title":"Lancet Glob Health"},{"key":"1402_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaf597","author":"E Rayens","year":"2025","unstructured":"Rayens E, Sy LS, Qian L, Ackerson BK, An J, Luo Y, et\u00a0al. Comparison of healthcare resource utilization and disease outcomes in adults hospitalized with human metapneumovirus and respiratory syncytial virus. J Infect Dis. 2025. https:\/\/doi.org\/10.1093\/infdis\/jiaf597.","journal-title":"J Infect Dis"},{"issue":"Supplement_1","key":"1402_CR21","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1093\/infdis\/jiaf084","volume":"232","author":"C Samoriski","year":"2025","unstructured":"Samoriski C, Chu C-Y, Falsey AR, Peterson D, Bhattacharya S, Croft DP, et\u00a0al. Clinical features and gene expression patterns in adults hospitalized with respiratory syncytial virus and human metapneumovirus infection. J Infect Dis. 2025;232(Supplement_1):S37\u201346.","journal-title":"J Infect Dis"},{"issue":"1","key":"1402_CR22","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s44337-025-00536-x","volume":"2","author":"AS Ishak","year":"2025","unstructured":"Ishak AS, Auwal AR, Maikifi AS, Musa SS, Dalhatu M, Musa A, et\u00a0al. Human Metapneumovirus: an emerging threat in respiratory viral infections and a public health concern. Discov Med. 2025;2(1):314.","journal-title":"Discov Med"},{"issue":"1","key":"1402_CR23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13613-024-01246-w","volume":"14","author":"DW de Lange","year":"2024","unstructured":"de Lange DW, Soliman IW, Leaver S, Boumendil A, Haas LEM, Watson X, et\u00a0al. The association of premorbid conditions with 6-month mortality in acutely admitted ICU patients over 80 years. Annal Inten Care. 2024;14(1):46.","journal-title":"Annal Inten Care"},{"issue":"8","key":"1402_CR24","doi-asserted-by":"publisher","first-page":"e1031","DOI":"10.1016\/S2214-109X(19)30264-5","volume":"7","author":"Y Li","year":"2019","unstructured":"Li Y, Reeves RM, Wang X, Bassat Q, Brooks WA, Cohen C, et\u00a0al. Global patterns in monthly activity of influenza virus, respiratory syncytial virus, parainfluenza virus, and metapneumovirus: a systematic analysis. Lancet Glob Health. 2019;7(8):e1031\u201345.","journal-title":"Lancet Glob Health"},{"issue":"1","key":"1402_CR25","doi-asserted-by":"publisher","first-page":"e107050","DOI":"10.1136\/bmjopen-2025-107050","volume":"16","author":"RK Philip","year":"2026","unstructured":"Philip RK, Mangroo K, Gendy N, Purtill H, Kelly E, Domegan L, et\u00a0al. Respiratory syncytial virus (RSV) notifications and trends in the transmission cycles from infants and young children to older adults in Ireland: an analysis of incidence shifts over a decade. BMJ Open. 2026;16(1):e107050.","journal-title":"BMJ Open"},{"issue":"3","key":"1402_CR26","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/infdis\/jiaf230","volume":"232","author":"K Li","year":"2025","unstructured":"Li K, Pitzer VE, Weinberger DM. Exploring RSV transmission patterns in different age groups in the United States. J Infect Dis. 2025;232(3):700\u20138.","journal-title":"J Infect Dis"},{"key":"1402_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2026-224843","author":"P Loubet","year":"2026","unstructured":"Loubet P, Nair H. Beyond age: comorbidity-informed stratification for RSV hospital outcomes. Thorax. 2026. https:\/\/doi.org\/10.1136\/thorax-2026-224843.","journal-title":"Thorax"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01402-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-026-01402-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-026-01402-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:24:08Z","timestamp":1786728248000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-026-01402-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1402"],"URL":"https:\/\/doi.org\/10.1007\/s40121-026-01402-8","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"assertion":[{"value":"19 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Richard Osei-Yeboah reports research contract from AstraZeneca. You Li reports grants from WHO, GSK, Pfizer and MSD (all to institution), and consulting fees from WHO, Pfizer, MSD and Sanofi for attending meetings outside the submitted work. Harish Nair reports grants to institution from MSD, Pfizer, Icosavax\/AstraZeneca, consulting fees to institution from WHO, Pfizer, Bill and Melinda Gates Foundation, and Sanofi, payments for lectures made to institution from AstraZeneca, GSK, and Pfizer, support for meetings from Sanofi and Pfizer, and board participation at GSK, Sanofi, Icosavax\/AstraZeneca, Pfizer, ResViNET, and WHO, with payments to institution and the latter two unpaid. Durga Kulkarni and Kate Templeton declared that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Public Benefit and Privacy Panel for Health and Social Care (PBPP-HSC) approved data access to the required data in the National Safe Haven (Approval number: 2223-0019). This research examined pseudonymised data that did not require patients\u2019 active consent. The data were collected routinely through NHS Scotland, with patients informed of potential use and their rights through various PHS and NHS Scotland privacy notices.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}